Lynx1 Capital Management LP 13D and 13G filings for Precision BioSciences, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-02-17 1:46 pm Sale | 2025-12-31 | 13G | Precision BioSciences, Inc. DTIL | Lynx1 Capital Management LP | 993,913 4.100% | -48,683 (-4.67%) | Filing |
| 2025-11-14 2:02 pm Purchase | 2025-09-30 | 13G | Precision BioSciences, Inc. DTIL | Lynx1 Capital Management LP | 1,042,596 8.800% | 276,545 (+36.10%) | Filing |
| 2025-02-14 09:01 am Purchase | 2024-12-31 | 13G | Precision BioSciences, Inc. DTIL | Lynx1 Capital Management LP | 766,051 9.990% | 766,051 (New Position) | Filing |